Active	Status	Sponsor type	Region	Phase	Filter
5 Active 3 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wit, Ferdinand
NCT04090151: The RESPOND Outcomes Study	Recruiting	N/A	37853	Europe, RoW		Rigshospitalet, Denmark, Gilead Sciences, ViiV Healthcare	HIV	12/25	12/25
Reiss, Peter
ORBIT, NCT06240520: Optimizing Reversal of HIV Latency With Combination Therapy	Not yet recruiting	1/2	49	Europe	Panobinostat 20 MG Oral Capsule, Pyrimethamine 200mg Oral Tablet, Lenalidomide 25 MG Oral Capsule	Erasmus Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, AIDSfonds	Hiv	05/25	10/25
agehIV, NCT01466582: Comorbidity and Aging With HIV	Active, not recruiting	N/A	1148	Europe		Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Public Health Service of Amsterdam	HIV-1-infection, Comorbidity, Ageing	10/40	10/40
NCT04090151: The RESPOND Outcomes Study	Recruiting	N/A	37853	Europe, RoW		Rigshospitalet, Denmark, Gilead Sciences, ViiV Healthcare	HIV	12/25	12/25
Wasmuth, Jan-Christian
NCT04090151: The RESPOND Outcomes Study	Recruiting	N/A	37853	Europe, RoW		Rigshospitalet, Denmark, Gilead Sciences, ViiV Healthcare	HIV	12/25	12/25